A detailed history of Strategic Global Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 9,878 shares of NVO stock, worth $863,040. This represents 0.23% of its overall portfolio holdings.

Number of Shares
9,878
Previous 5,999 64.66%
Holding current value
$863,040
Previous $856,000 37.38%
% of portfolio
0.23%
Previous 0.18%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $461,872 - $564,084
3,879 Added 64.66%
9,878 $1.18 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $715,276 - $856,338
-5,829 Reduced 49.28%
5,999 $856,000
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $10,823 - $14,407
-106 Reduced 0.89%
11,828 $1.52 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $25,807 - $31,002
-294 Reduced 2.4%
11,934 $1.23 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $571,103 - $1.25 Million
6,280 Added 105.58%
12,228 $1.11 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $133,206 - $147,443
854 Added 16.76%
5,948 $962,000
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $13,498 - $16,232
-102 Reduced 1.96%
5,094 $810,000
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $1,025 - $1,353
-10 Reduced 0.19%
5,196 $703,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $23,248 - $28,530
244 Added 4.92%
5,206 $519,000
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $512,276 - $604,421
4,962 New
4,962 $553,000
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $816,034 - $996,467
-8,511 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $840,654 - $1.06 Million
-9,958 Reduced 53.92%
8,511 $817,000
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $1.25 Million - $1.57 Million
18,469 New
18,469 $1.55 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Strategic Global Advisors, LLC Portfolio

Follow Strategic Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Global Advisors, LLC with notifications on news.